Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Jost, C; Hermann, J; Caelen, Lel-S; Graninger, W.
New onset psoriasis in a patient receiving abatacept for rheumatoid arthritis.
BMJ Case Rep. 2009; 2009(7): Doi: 10.1136/bcr.09.2008.0845 [OPEN ACCESS]
PubMed FullText FullText_MUG

Leading authors Med Uni Graz: Granitz Christina
Co-authors Med Uni Graz: Graninger Winfried; Hermann Josef
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: Administration of abatacept is a new treatment modality for rheumatoid arthritis (RA). We describe a patient in whom psoriasiform skin lesions developed 4 months after the initiation of abatacept therapy for longstanding, rheumatoid factor positive RA. Histological findings were consistent with psoriasis. The skin lesions subsided after discontinuation of abatacept and reappeared after re-exposure to the drug, suggesting a causal connection between abatacept and the development of psoriasis.